Main content
CSL Behring Products
Major plasma products marketed by CSL Behring
Haemophilia and Other
Coagulation Disorders
Coagulation therapies are used to treat bleeding disorders such as haemophilia and von Willebrand disease.
Plasma-derived Factor VIII and von Willebrand Factor
- Beriate® P
- Monoclate-P®
- Humate-P®
- Haemate® P
- Biostate®
Recombinant Factor VIII
- Helixate® FS
- Helixate® NexGen
- Plasma-derived Factor IX
- Berinin® P
- Mononine®
Plasma-derived Factor X
- Factor X P
Other Products
- Stimate®
- Octostim®
- Minirin®
Critical Care Conditions
Critical care products are used to treat shock, sepsis and severe burns, and are used in cardiac surgery.
Coagulation Disorders
- Beriplex® P/N
- Fibrogammin® P
- Haemocomplettan® P
- Kybernin® P
Trauma Therapies
- Albuminar®
- Human Albumin
- AlbuRxTM
Other Critical Care
- Berinert® P
- Minirin® Parenteral
- Innohep®
- Streptase®
Wound Healing
Wound healing therapies are used to facilitate healing.
- Beriplast® P
- Tachocomb®
Immune Disorders and Immune Therapy
Immunoglobulins are used to treat infections and autoimmune diseases, and to prevent haemolytic disease in the newborn.
Polyvalent Immunoglobulins
- Privigen®
- Carimune® NF
- Redimune®
- Redimune® NF Liquid
- Sandoglobulin®
- Sandoglobulin® NF Liquid
- Sanglopor®
- Lymphoglobuline®
Subcutaneous Immunoglobulins
- Vivaglobin®
Specific Immunoglobulins
- Beriglobin® P
- Berirab® P
- Hepatitis B Immunoglobulin
- Rhophylac®
- Tetagam®
- Varicellon®
- Cytogam®
Alpha 1-Proteinase Inhibitor Deficiency
For people at risk from life-shortening emphysema through a genetic deficiency in their synthesis of this protein.
- Zemaira®
For more information about these products, see www.cslbehring.com